Doximity (DOCS) Stock Price, News & Analysis

Company Overview

Doximity, Inc. operates a digital platform designed for medical professionals in the United States. Its network connects physicians, nurse practitioners, physician assistants, pharmacists and other healthcare professionals, providing tools for professional communication, collaboration and career development.

The company offers services including secure messaging, telehealth, digital faxing, physician scheduling and professional networking. Doximity also provides medical news and educational content, as well as recruiting and job-search resources for healthcare professionals.

Doximity generates additional revenue through digital marketing and engagement solutions for pharmaceutical companies, healthcare organizations and health systems. These services help clients communicate with medical professionals through the company’s online platform.

Founded in 2010, Doximity is headquartered in San Francisco, California, and primarily serves the U.S. healthcare market. The company was co-founded by Jeff Tangney, who serves as chief executive officer, along with Nate Gross and Shari Buck.

Key Stats

• Today's Range: $32.44 to $33.25
• 50-Day Range: $24.18 to $33.70
• 52-Week Range: $17.15 to $69.00
• Volume: 2.01 million shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $30.73
• Consensus Rating: Hold

Doximity Stock Analysis - MarketRank™

Doximity scored higher than 61% of companies evaluated by MarketBeat, and ranked 445th out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.1 / 5
• Analyst Rating: Hold

Consensus Rating

Doximity has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on no strong buy ratings, 8 buy ratings, 14 hold ratings, and 3 sell ratings.

Downside Risk

Doximity has a consensus price target of $30.73, representing about 7.4% downside from its current price of $33.17.

Amount of Analyst Coverage

Doximity has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 28.38%

Earnings Growth

Earnings for Doximity are expected to grow by 28.38% in the coming year, from $0.74 to $0.95 per share.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

7.47% of the float of Doximity has been sold short.

Short Interest Ratio / Days to Cover

Doximity has a short interest ratio ("days to cover") of 2.76, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Doximity has recently decreased by 19.49%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Doximity does not currently pay a dividend.

Dividend Growth

Doximity does not have a long track record of dividend growth.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.10

News Sentiment

Doximity has a news sentiment score of 0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 25 news articles for Doximity this week, compared to 8 articles on an average week.

Search Interest

Only 3 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -63% compared to the previous 30 days.

MarketBeat Follows

2 people have added Doximity to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.1 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $613,855.00 in company stock.

Percentage Held by Insiders

31.80% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 10/27/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NYSE:DOCS
• Previous Symbol: NASDAQ:DOCS
• CIK: 1516513
• Web: doximity.com
• Phone: (650) 549-4330
• Fax: N/A
• Employees: 880
• Year Founded: 2010

Price Target and Rating

• Average Price Target for Doximity: $30.73
• High Price Target: $50.00
• Low Price Target: $18.00
• Potential Upside/Downside: -7.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.20
• Research Coverage: 25 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: 121,564,000
• Market Cap: N/A
• Optionable: Optionable
• Beta: N/A